Pharmacokinetics, safety and tolerability of empagliflozin, a sodium glucose cotransporter 2 inhibitor, in patients with hepatic impairment. (Q47998345)
Jump to navigation
Jump to search
scientific article published on 19 August 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacokinetics, safety and tolerability of empagliflozin, a sodium glucose cotransporter 2 inhibitor, in patients with hepatic impairment. |
scientific article published on 19 August 2013 |
Statements
1 reference
Pharmacokinetics, safety and tolerability of empagliflozin, a sodium glucose cotransporter 2 inhibitor, in patients with hepatic impairment. (English)
1 reference
S Macha
1 reference
P Rose
1 reference
M Mattheus
1 reference
R Cinca
1 reference
S Pinnetti
1 reference
U C Broedl
1 reference
H J Woerle
1 reference
19 August 2013
1 reference
16
1 reference
118-123
1 reference
2
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference